诺瓦瓦克斯医药(NVAX.US)今日盘中大涨14.78%,引发市场关注。
诺瓦瓦克斯医药当日将其位于捷克的一家生产设施以2亿美元的价格出售给诺和诺德公司。这笔交易将为诺瓦瓦克斯医药带来巨额现金收益,增强公司的财务实力。同时也将使公司每年运营成本降低约8000万美元,提高了运营效率。
诺瓦瓦克斯医药表示,此举符合公司之前宣布的承诺,即专注于自身管线资产和技术平台。投资者对公司战略调整和前景抱有信心,推动股价今日大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.